MD Anderson Cancer Center Madrid

Madrid, Calle de Arturo Soria 270

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia

Studies at this site

• A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early